to page content
to site navigation
Kavita N. Ramdas has won numerous awards for her vision and advancement of an inclusive philanthropy in which donors and grantees are treated as equal partners. In 2005, Kavita received the Juliette Gordon Low Award for
her significant contributions to advancing women's human rights and for being exemplary role model for girls and women. In 2004, Financial Women's Association named Kavita Woman of the Year for the Public Sector; and Women and Philanthropy
gave her the LEAD (Leadership for Equity and Diversity) Award for her championship and commitment to funding the global human rights of women and girls. KQED public television recognized her as a 2004 Bay Area Local Hero. She serves on the
Board of Trustees of Mount Holyoke College, Massachusetts, and the Board of Directors of the Rural Development Institute, Washington state. She is a member of the Advisory Council to the Ethical Globalization Initiative, a venture of Mary
Robinson, former UN High Commissioner for Human Rights. She also serves on the Council of Advisors on Gender Equity to the Woodrow Wilson School at Princeton University and the Women's Rights Prize of the Gruber Foundation. Before joining
the Global Fund, Kavita supported both domestic and international initiatives in economic development and population as a program officer at the John D. and Catherine T. MacArthur Foundation in Chicago, Illinois. She earned a master's
degree in international development and public policy at the Woodrow Wilson School of Public and International Affairs at Princeton University, and a BA at Mount Holyoke College. Kavita was born and raised in India, and speaks Urdu, Hindi,
English, German, French and Spanish.
Dr. Ringold was most recently CEO of the Glaxo-Wellcome Group's Affymax Research Institute, where he managed the development of novel technologies to accelerate the pace of drug discovery. He is a co-founder and director
of Maxygen Corporation, a Managing Partner of Technogen Associates, L.P., a private investment firm, and has over fifteen years of experience managing the discovery and development of pharmaceuticals and novel, enabling life science
technologies. Prior to Affymax, Dr. Ringold served as Director and Vice President of the Institute for Cancer and Developmental Biology at Syntex, now a division of Hoffman La-Roche. Dr. Ringold received his B.A. in Biology from UC Santa
Cruz, and his Ph.D. in Microbiology from UC San Francisco. He was on the faculty of the Department of Pharmacology at the Stanford University School of Medicine, and is currently a consulting professor there.
Guy Kawasaki is a founder and Managing Director of Garage Technology Ventures. Prior to this position, he was an Apple Fellow at Apple Computer, Inc. and sits on the board of BitPass Inc. A noted speaker and the founder
of various personal computer companies, Guy was one of the individuals responsible for the success of the Macintosh computer. He is also the author of eight books including Rules for Revolutionaries, How to Drive Your Competition Crazy,
Selling the Dream, and The Macintosh Way. Guy holds a B.A. from Stanford University and a M.B.A. from UCLA, as well as an honorary doctorate from Babson College.
Julio C. Palmaz, M.D., is the inventor of the first commercially successful stent and has developed numerous other procedures and devices, including the stent graft. Millions of patients worldwide, including stent
recipient Mother Teresa, have benefited from the inventions of Dr. Palmaz, some of which have been donated to the Smithsonian Institute. Dr. Palmaz is the Stewart R. Reuter Distinguished Professor and chief of cardiovascular and
interventional radiology at the University of Texas Health Science Center. Dr. Palmaz received his M.D. in 1971 at the National University of La Plata, Argentina, with radiologic specialty training at the University of California at Davis,
Martinez Veteran's Administration Medical Center. Dr. Palmaz began his professional career in 1974 at San Martin University Hospital in Argentina, where he attained the position of chief of angiography. In 1983, Dr. Palmaz joined the
University of Texas Health Sciences Department of Radiology as Chief of Angiography and Special Procedures. Dr. Palmaz has 17 issued patents and is the author of over 26 books or book chapters and has authored more than 75 peer-reviewed
publications. He is Member of the Editorial Board for Circulation and is a Scientific Reviewer for several journals including the Journal of Vascular Surgery and the Journal of Vascular, Interventional Radiology. Palmaz is the recipient of
numerous awards, and was honored January 2003 with the Presidential Distinguished Scholar Award by the University of Texas San Antonio. In 2002, the International Society of Endovascular Surgery bestowed upon Dr. Palmaz the Honor Award for
Jen-Hsun Huang co-founded NVIDIA Corporation in April 1993 and has served as President, Chief Executive Officer, and a member of the Board of Directors since its inception. Under his leadership, NVIDIA has become one of
the largest fabless semiconductor companies in the world. NVIDIA has received numerous business and technology awards during Mr. Huang's tenure, including Fortune's Fastest Growing Companies, Wired Magazine's Top 40, and Stanford Business
School's Entrepreneurial Company of the Year. Mr. Huang has served as on the Board of Trustees of the RAND Corporation since 1999 and is often invited to speak on technology and business trends at industry events. Prior to founding NVIDIA,
Mr. Huang was Director of Coreware at LSI Logic and a microprocessor designer at Advanced Micro Devices. Mr. Huang holds a B.S.E.E. degree from Oregon State University and an M.S.E.E. degree from Stanford University.
Thomas J. Fogarty is a specialist whose creative talents have impacted many diverse professional and entrepreneurial arenas. In addition to his teaching responsibilities as Professor of Surgery at Stanford University,
Dr. Fogarty performs numerous cardiac and peripheral vascular surgeries, manages several medical device companies founded upon his product designs, is founder and active Senior Partner in the venture capital firm of Three Arch Partners,
and also finds time to pursue his interest in oenology at the family owned and operated Thomas Fogarty Winery and Vineyards. During the past 40 years he has acquired over 70 surgical patents, including the "industry standard" Fogarty
balloon embolectomy catheter. Patented in 1969, this first balloon catheter for the vascular system was a sophisticated version of the original crude instrument that young Tom Fogarty, then an OR scrub technician, designed in the late
1950's using a surgical glove finger tied to a ureteral catheter. Other commercially successful medical products designed by the Fogarty engineering group include a minimally invasive device for breast cancer diagnosis and therapy, and
also a self-expanding stent-graft used to treat critical aortic aneurysms via a minimally invasive technique. Dr. Fogarty is a past recipient of the Inventor of the Year award given by the San Francisco Patent and Trademark Association, a
four-time recipient of the Distinguished Scientific Presentation award presented by the American College of Surgeons, and was the first recipient to receive the award for "Achievement in Medicine" bestowed by the Santa Clara County Medical
Association. Selected recent awards include the 2000 Lemelson-MIT $500,000 Prize for Invention and Innovation as well as the Association for Advancement of Medical Instrumentation Foundation's Annual Laufman-Greatbatch Prize for inventing
breakthrough medical devices. Later in 200
Paul G. Yock, M.D. is the Martha Meier Weiland Professor of Medicine and Professor of Mechanical Engineering, by courtesy. Dr. Yock is Co-Chair of Stanford's new Department of Bioengineering and Director of the Stanford
Program in Biodesign. Dr. Yock is a Stanford cardiologist internationally known for his work in inventing, developing and testing new devices, including the Rapid Exchange balloon angioplasty system, which is the dominant angioplasty
system in use worldwide. Yock also invented a Doppler-guided hypodermic needle system, the Smart Needle and P-D Access. Dr. Yock is Director of the Center for Research in Cardiovascular Interventions, a Stanford facility that develops and
tests new technologies in cardiovascular medicine. The focus of Dr. Yock's research program is the field of intravascular ultrasound. He authored the fundamental patents for intravascular ultrasound imaging and founded Cardiovascular
Imaging Systems, now a division of Boston Scientific resulting from a 1994 acquisition for over $100M. In 1998 Dr. Yock developed a new interdepartmental and inter-school program at Stanford, the Medical Device Network (MDN). MDN helps
stimulate and guide the process of biomedical technology innovation within the University. Recently MDN has been expanded under Dr. Yock's leadership into a broader research and educational initiative, the Stanford Program in Biodesign.
MDN is now BDN, the Biodesign Network. The primary mission of Biodesign is to promote the invention and implementation of new health technologies through interdisciplinary research and education at the frontiers of engineering and the
Jeff Hawkins is the Founder of Numenta, but he is also well known as the co-founder of two companies, Palm and Handspring, and as the architect of many computing products, such as the PalmPilot and the Treo smartphone.
Throughout his life Hawkins has also had a deep interest in neuroscience and theories of the neocortex. His interest in the brain led him to create the non-profit Redwood Neuroscience Institute (RNI), a scientific organization focused on
understanding how the human neocortex processes information. While at RNI, Hawkins developed a theory of neocortex which appeared in his 2004 book, On Intelligence. Along with Dileep George and Donna Dubinsky, Hawkins
founded Numenta in 2005 to develop a technology platform derived from his theory. It is his hope that Numenta will play a catalytic role in creating an industry based on this theory and technology. Jeff Hawkins earned his B.S. in
electrical engineering from Cornell University in 1979. He was elected to the National Academy of Engineering in 2003.
Google founders Larry Page and Sergey Brin recruited Eric Schmidt from Novell, where he led that company's strategic planning, management and technology development as chairman and CEO. Since coming to Google, Schmidt
has focused on building the corporate infrastructure needed to maintain Google's rapid growth as a company and on ensuring that quality remains high while product development cycle times are kept to a minimum. Along with Page and Brin,
Schmidt shares responsibility for Google's day-to-day operations. Schmidt's Novell experience culminated a 20-year record of achievement as an Internet strategist, entrepreneur and developer of great technologies. Schmidt's well-seasoned
perspective perfectly complements Google's needs as a young and rapidly growing search engine with a unique corporate culture. Prior to his appointment at Novell, Schmidt was chief technology officer and corporate executive officer at Sun
Microsystems, Inc., where he led the development of Java, Sun's platform-independent programming technology, and defined Sun's Internet software strategy. Before joining Sun in 1983, Schmidt was a member of the research staff at the
Computer Science Lab at Xerox Palo Alto Research Center (PARC), and held positions at Bell Laboratories and Zilog. Schmidt has a bachelor of science degree in electrical engineering from Princeton University, and a master's and Ph.D. in
computer science from the University of California-Berkeley.
Vinod grew up dreaming of being an entrepreneur. He was raised in an Indian Army household with no business or technology connections. When, at age 16, he first heard about Intel, he dreamt of starting his own technology
company. Upon graduating with a Bachelors in Electrical Engineering from the Indian Institute of Technology, Delhi, he tried to start a soy milk company to service the many people in India who did not have refrigerators. He then came to
the US and got his Masters in Biomedical Engineering at Carnegie-Mellon University. His startup dreams attracted him to Silicon Valley where he got an MBA at Stanford University in 1980. In 1982, Khosla started Sun Microsystems to build
workstations for software developers. At Sun he pioneered "open systems" and RISC processors. Sun was funded by long time friend and board member John Doerr of Kleiner Perkins Caufield & Byers. In 1986 he switched sides and joined
Kleiner Perkins where he was a general partner. There, he worked with Nexgen/AMD, Juniper, Excite, and many other ventures. In 2004, Khosla formed Khosla Ventures. Khosla Ventures offers venture assistance, strategic advice and capital to
entrepreneurs. The firm helps entrepreneurs extend the potential of their ideas in both traditional venture areas like the Internet, computing, mobile, and silicon technology arenas but also supports breakthrough scientific work in clean
technology areas such as bio-refineries for energy and bioplastics, solar, battery and other environmentally friendly technologies.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.